News | January 20, 2023
Blue Jet Healthcare gets SEBI nod for IPO
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
Formulation revenue decreased by 7.6% YoY to Rs. 4,770 crore whereas in Q2 FY23, API business posted a growth of 24.2% YoY with revenue of Rs. 969.4 crore
For the last ten financial years, the company has posted healthy performance with its revenue from operations growing at 15% CAGR and net profit at 23% CAGR
Extended Phenytoin Sodium Capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures
He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets
Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia
The company was directed to submit a plan of compliance by July 15, 2022
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Subscribe To Our Newsletter & Stay Updated
